research update - Page 1 | CARLAT PUBLISHING

Research Update

Some Antidepressants May Help Longer Than Others

April 1, 2025

Jeremy Mills, DNP, PMHNP-BC

Jeremy Mills, DNP, PMHNP-BC. Dr. Mills has no financial relationships with companies related to this material.

A large Danish study ranks antidepressants by their preventative effects.

Research Update

Proposed Treatment Algorithm for Postpartum Psychosis

March 1, 2025

Alex Evans, PharmD, MBA.

Alex Evans, PharmD, MBA. Dr. Evans has no financial relationships with companies related to this material.

Zuranolone (Zurzuvae) may be FDA-approved for postpartum depression, but we need a very different medication approach for the 1-2 in 1,000 who develop postpartum psychosis.

Top 10 Findings: Alcohol, ADHD, and Antipsychotics

October 28, 2024

Chris Aiken, MD and Kellie Newsome, PMHNP

A new med combo for alcohol use disorder, antipsychotic dose reduction in schizophrenia, and two new tips for using stimulants in ADHD.

Top 10 Findings: Lithium, Lumateperone, and Lavender

October 21, 2024

Chris Aiken, MD and Kellie Newsome, PMHNP

New studies change how we think about lithium and weight gain, and updates on lumateperone, lavender, and esketamine in depression.

Top 10 Findings of Past Year: Treatment Resistant Depression and Benzos

October 14, 2024

Chris Aiken, MD and Kellie Newsome, PMHNP

We count down the top 10 research updates of the past year with a focus on treatment resistant depression and benzo withdrawal.

Research Update

High-Dose Stimulants in Adult ADHD

September 3, 2024

Sy Clark, MD

Sy Clark, MD. Dr. Clark has no financial relationships with companies related to this material.

Finding the right stimulant dose for adult ADHD can be tough. This study looked at how higher doses beyond FDA limits affect symptom control and side effects.

RESEARCH UPDATE

Side Effects in Depression

October 30, 2022

Fernando Espí Forcén, MD. Dr. Forcén has no financial relationships with companies related to this material.

Side effects are burdensome to patients, but do they also get in the way of recovery? This study sought to clarify how side effects change over time and whether they impede recovery in major depressive disorder.

RESEARCH UPDATE

Who Responds to SSRIs in PTSD?

October 30, 2022

Richard Moldawsky, MD

Richard Moldawsky, MD. Dr. Moldawsky has no financial relationships with companies related to this material.

SSRIs are often used in PTSD, but it is not clear that they work for all kinds of trauma. Trials of SSRIs are generally positive in women and people with a history of sexual trauma, while trials involving combat-related trauma tend to be negative. The current study aimed to better identify predictors of response.

RESEARCH UPDATE

Pediatric Bipolar Depression: How Do We Rate a New Meta-Analysis?

October 1, 2022

Sibel Algon, MD.

Dr. Algon, author of this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.

Clinicians use olanzapine, mirtazapine, and other appetite-inducing medications off label to treat ARFID, but with little research to support their use. This study unpacks the potential role of medications in treating comorbid symptoms associated with ARFID.

RESEARCH UPDATE

SSRIs and Hydroxyzine for Avoidant/Restrictive Food Intake Disorder (ARFID)?

October 1, 2022

Joshua Feder, MD

Dr. Feder, author of this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.

Clinicians use olanzapine, mirtazapine, and other appetite-inducing medications off label to treat ARFID, but with little research to support their use. This study unpacks the potential role of medications in treating comorbid symptoms associated with ARFID.